Meridian Recalls Diazepam Autoinjectors Due to High Carbostyril Levels
Meridian Medical Technologies is recalling 83,400 Diazepam autoinjectors because they contain high levels of carbostyril, a known degradation product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving significant quality deviations like high out-of-specification degradation products.
Plain-English summary
Meridian Medical Technologies, a Pfizer Company, is recalling 83,400 units of Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use. The recall is being conducted because the product contains high out-of-specification levels of carbostyril, which is a known degradation product of diazepam.
The affected product is distributed nationwide, as well as in military settings, Italy, Singapore, Sweden, and Canada. The specific lots involved are 8D1082 (expiration 01/13) and 8D1151 (expiration 03/13). The product is identified by NDC 11704-600-01 and NSN 6505-01-274-0951.
Consumers and healthcare providers should stop using the affected autoinjectors and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- DIAZEPAM (DIAZEPAM)
- Brand
- DIAZEPAM
- Manufacturer
- Meridian Medical Technologies a Pfizer Company
- Category
- Drug — Prescription Injection
- Affected units
- 83,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 8D1082
- Exp 01/13
- 8D1151
- Exp 03/13
UPCs (1)
- 0311704600015
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DIAZEPAM
- LowValeant Recalls Diazepam Rectal Gel Due to Missing Lot and Expiration Dates
FDA (Drugs) · 2018-08-15
- SevereHospira Recalls Diazepam Injection Due to Crystallized Active Ingredient
FDA (Drugs) · 2016-07-20
- SevereHospira Recalls Diazepam Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2013-09-04
- SevereHospira Recalls Diazepam Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2013-06-12
- SevereHospira Recalls Diazepam Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-15
Same manufacturer · Meridian Medical Technologies a Pfizer Company
See all →- CriticalEpiPen Jr. Auto-Injectors Recalled for Delivery System Defects
FDA (Drugs) · 2017-05-10
- CriticalEpiPen Auto-Injectors Recalled for Defective Delivery System
FDA (Drugs) · 2017-05-10
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17